ProofPilot completed the acquisition of Lokavant.

ProofPilot, a technology company specializing in patient recruitment and site engagement solutions designed to enhance the clinical trial experience, completed the acquisition of Lokavant, a clinical intelligence company that improves trial execution through its data-driven analytics platform. Financial terms were not disclosed. "ProofPilot has long demonstrated a commitment to empowering sponsors and research teams with the tools they need to execute successful trials. By bringing Lokavant's predictive analytics engine into our platform, we're equipping our customers with an industry first ability to measure and predict success in real time by combining study stakeholder behaviors and real time study data," Chris Venezia, ProofPilot CEO.